Marc Blaustein, Chief Operating Officer at Finch Therapeutics Group, Inc. (FNCH), sold 3,636 shares at $1.39 ($5K) on 2022-10-21, disclosed to the SEC on 2022-10-25.
Open-market sale of $5k FNCH by Chief Operating Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.